| Temperate phage-antibiotic synergy eradicates bacteria through depletion of lysogens AM Al-Anany, R Fatima, AP Hynes Cell Reports 35 (8), 2021 | 68 | 2021 |
| Circulatory miR-221 & miR-542 expression profiles as potential molecular biomarkers in Hepatitis C Virus mediated liver cirrhosis and hepatocellular carcinoma MB Yasser, M Abdellatif, E Emad, A Jafer, S Ahmed, L Nageb, ... Virus Research 296, 198341, 2021 | 19 | 2021 |
| Phage therapy in the management of urinary tract infections: a comprehensive systematic review AM Al-Anany, PB Hooey, JD Cook, LL Burrows, J Martyniuk, AP Hynes, ... Phage 4 (3), 112-127, 2023 | 13 | 2023 |
| Investigating circulatory microRNA expression profiles in Egyptian patients infected with hepatitis C virus mediated hepatic disorders AA Gibriel, AM Al-Anany, MAE Al-Arab, HME Azzazy Meta gene 26, 100792, 2020 | 10 | 2020 |
| Temperate phage-antibiotic synergy eradicates bacteria through depletion of lysogens. Cell Rep 35: 109172 AM Al-Anany, R Fatima, AP Hynes | 6 | 2021 |
| Temperate Phage-Antibiotic Synergy Eradicates Bacteria Through Depletion of Lysogens AM Al-Anany, R Fatima, A Hynes Available at SSRN 3677224, 2020 | 1 | 2020 |
| Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny AM Al-Anany, R Fatima, G Nair, JT Mayol, AP Hynes Mbio 15 (6), e00504-24, 2024 | | 2024 |
| Temperate Phage-Antibiotic Synergy A Al-Anany | | 2024 |
Alexander HynesMcMaster University在 mcmaster.ca 的电子邮件经过验证
